Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01864304 · ClinicalTrials.gov registry record

Fat Distribution and Glucose Metabolism in Williams Syndrome

A clinical trial, sponsored by Massachusetts General Hospital.

Completed
Registry status
24
Enrollment target

NCT01864304: Completed study, sponsored by Massachusetts General Hospital.

NCT01864304 is a clinical trial that has completed, run by Massachusetts General Hospital. The registered enrollment target is 24 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT01864304 has completed, sponsored by Massachusetts General Hospital.

COMPLETED
Registry status
24 participants
Enrollment target

Study Summary

Williams Syndrome (WS) is a genetic syndrome with features that may include vascular stenoses, neuro-developmental changes, and a variety of endocrine and metabolic abnormalities, including impaired glucose metabolism and abnormal body composition. Approximately 75% of adults with WS have impaired glucose tolerance or diabetes on oral glucose tolerance testing (OGTT). In addition, clinical observations and preliminary data suggest increased overall body fat in these individuals, as well as a relative increase in fat deposition in the lower extremities. However, glucose and lipid metabolism in WS remain incompletely characterized. The purpose of the current study is to carefully describe glucose metabolism and lipid parameters in people with WS.

Primary Outcome

Blood glucose concentration two hours after drinking a sugary drink (oral glucose tolerance test)

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2013-12
Est. Completion 2016-02
Massachusetts General Hospital

2,032 total trials

What the finished NCT01864304 record still lists

NCT01864304 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 24 participants, a relatively small participant target.

The record links to 0 conditions, and to 0 interventions.

NCT01864304 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01864304 about?

NCT01864304 is a clinical study titled "Fat Distribution and Glucose Metabolism in Williams Syndrome". Williams Syndrome (WS) is a genetic syndrome with features that may include vascular stenoses, neuro-developmental changes, and a variety of endocrine and metabolic abnormalities, including impaired glucose metabolism and abnormal body composition. Approximately 75% of adults with WS have impaired g...

What is the current status of trial NCT01864304?

This trial is currently completed. The enrollment target is 24 participants. The study started on 2013-12. Estimated completion is 2016-02.

Who is sponsoring clinical trial NCT01864304?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02331979 · 24 participants · NA

    Improving Bladder Function in SCI by Neuromodulation

  • NCT03096197 · 24 participants · NA

    Exoskeleton and Spinal Cord Stimulation for SCI

  • NCT03223922 · 24 participants · NA

    Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases

  • NCT03326921 · 24 participants · Phase 1

    HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01864304, the US trial registry maintained by the National Library of Medicine. NCT01864304 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.